Feedback

Extracorporeal Membrane Oxygenation (ECMO)

Zasha Vázquez – Colón, MD, Yuriy Stukov, MD, Jeffrey P Jacobs, MD, Mark S Bleiweis, MD, Giles J. Peek, MD
Extracorporeal Membrane Oxygenation (ECMO) is a topic covered in the Adult and Pediatric Cardiac.

To view the entire topic, please or .

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

-- The first section of this topic is shown below --

Introduction

Extracorporeal membrane oxygenation (ECMO) can provide lifesaving respiratory and cardiac support for patients when maximal conventional therapy is failing. With 45 years of experience since the first successful use of ECMO to support a neonate with respiratory failure, ECMO has been utilized to support neonates, infants, children, and adults with a variety of congenital and acquired respiratory and cardiac diseases. The pathophysiological mechanisms in neonatal versus pediatric respiratory failure are different. Limited alveolar gas exchange versus oxygenation failure due to inadequate pulmonary blood flow with pulmonary hypertension differentiate the common forms of pediatric and neonatal respiratory failure. Meanwhile, neonates, infants, children and adults with congenital and acquired cardiac disease may require mechanical circulatory support secondary to hemodynamic instability due to their critical cardiac lesions. Indications for cardiac ECMO include low cardiac output syndrome (often peri-operative), refractory arrhythmias, cardiogenic shock, septic shock, and cardiopulmonary resuscitation.[1] In these and other settings, ECMO may be used as a treatment option by building a bridge to therapy, bridge to decision, bridge to transplantation (including heart transplantation, lung transplantation, and combined heart and lung transplantation) or bridge to recovery.

-- To view the remaining sections of this topic, please or --

Introduction

Extracorporeal membrane oxygenation (ECMO) can provide lifesaving respiratory and cardiac support for patients when maximal conventional therapy is failing. With 45 years of experience since the first successful use of ECMO to support a neonate with respiratory failure, ECMO has been utilized to support neonates, infants, children, and adults with a variety of congenital and acquired respiratory and cardiac diseases. The pathophysiological mechanisms in neonatal versus pediatric respiratory failure are different. Limited alveolar gas exchange versus oxygenation failure due to inadequate pulmonary blood flow with pulmonary hypertension differentiate the common forms of pediatric and neonatal respiratory failure. Meanwhile, neonates, infants, children and adults with congenital and acquired cardiac disease may require mechanical circulatory support secondary to hemodynamic instability due to their critical cardiac lesions. Indications for cardiac ECMO include low cardiac output syndrome (often peri-operative), refractory arrhythmias, cardiogenic shock, septic shock, and cardiopulmonary resuscitation.[1] In these and other settings, ECMO may be used as a treatment option by building a bridge to therapy, bridge to decision, bridge to transplantation (including heart transplantation, lung transplantation, and combined heart and lung transplantation) or bridge to recovery.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: August 25, 2021